Atlas Trials

Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer

Clinical trial NCT02646228 · UNKNOWN

Trial details

NCT number
NCT02646228
Sponsor
Samsung Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Metastatic Cancer
Start date
2016-02-04
Primary completion
2022-06-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.